Press Release FeedGet the RSS feed
Menu

Business Wire

MiiHealth AI Closes Seed Round for an Undisclosed Amount to Reinvent Patient Intake and Give Providers Back Two Hours a Day

Business Wire

The funding accelerates deployment of the first agentic medical assistant that autonomously calls patients before visits, captures structured clinical histories, and writes intake notes directly into the EHR, thereby reshaping how health systems approach the front door of care.

PHOENIX, August 26, 2026--MiiHealth AI, maker of the first agentic AI medical assistant purpose-built to automate patient intake, today announced the closing of a seed funding round for an undisclosed amount led by Russell Glass, former CEO of Headspace and founder of Arteria Capital. The round includes participation from a select group of physician angels, healthcare operators, and digital health founders.

MiiHealth AI's assistant, DAINA (Dynamic AI Intake and Navigation Agent), autonomously calls patients before their appointments, conducts a natural, multi-turn clinical intake interview in the patient's preferred language, and writes a structured, clinician-ready note directly into the chart, all without requiring the provider to be present. By shifting intake work upstream and out of the exam room, DAINA prepares the chart before every visit and gives providers back more than two hours a day that would otherwise be spent on repetitive questioning and manual documentation. This additional capacity gives providers the flexibility to spend more time with each patient, as well as to undertake more billable activities.

"This raise fuels our next chapter: a more trustworthy clinical Agent, deeper roots across 70% of the country's EHR landscape, and a market position that sets a new standard for what AI-driven care looks like," said Kelvin Summoogum, founder and CEO of MiiHealth AI.

DAINA has already completed successful clinical validation in some of the most demanding environments in medicine. In a large cardiology deployment at Mayo Clinic, the assistant completed agentic intake across hundreds of patients, delivering measurable returns through significant provider time savings per encounter and exceptionally high levels of patient trust and comfort in sharing sensitive health information. Early results showed that patients found DAINA empathetic and easy to use. Providers were able to reclaim significant time from the intake process while maintaining clinical quality.

"MiiHealth AI automates patient intake, one of the most overlooked and painful parts of the clinical workflow," said Russell Glass, Founder of Arteria Capital and former CEO of Headspace. "Without asking clinicians to change how they practice, MiiHealth saves more than 8 minutes per cardiology encounter at Mayo Clinic, and patients love it. This is the kind of easy-to-implement and scalable win-win that health systems are looking for."

  1. HealthcareBeOne Medicines Ltd.BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancer Brain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient dataset First clinical data of CEA
  2. HealthcareCatalYmCatalYm Presents Phase 2 Data Showing Visugromab Substantially Enhances the Clinical Benefit of PD-1 Inhibition in Neoadjuvant Bladder Cancer at ESMO 2026Visugromab combined with PD-1 inhibitor nivolumab demonstrated higher response rates versus nivolumab alone across primary and secondary endpoints: pathologic Complete Response (pCR; 33% vs. 8%), radiographic Objective Response Rate (ORR; 60% vs. 15%) and Major Pathologic Response (MPR; 60% vs. 23%) Enhanced responses wer
  3. Real estateSlate Grocery REITSlate Grocery REIT Announces Receipt of Interim Order, and Provides Meeting and Circular DetailsTORONTO, October 24, 2026--Slate Grocery REIT (TSX: SGR.U) (TSX: SGR.UN) (the "REIT"), an owner and operator of U.S. grocery-anchored real estate, announced today that it has obtained an interim order (the "Interim Order") of the Ontario Superior Court of Justice (Commercial List) (the "Court") in conn
  4. Investing & marketsGenesis Healthcare, Inc.Genesis Healthcare Announces Effective Date of Chapter 11 Plan Following Consummation of Sale to West State StreetKENNETT SQUARE, Pa., October 24, 2026--Genesis Healthcare, Inc. ("Genesis") today announced that its chapter 11 plan became effective, following the closing of the sale of substantially all of its operating assets to 101 W. State Street, LLC ("West State Street") on October 14, 2026. On behalf of the B
  5. BankingUS Metro BancorpUS Metro Bancorp Announces Third Quarter 2026 ResultsGARDEN GROVE, Calif., October 23, 2026--US Metro Bancorp (OTCQX: USMT): US Metro Bancorp ("Bancorp") is a bank holding company, with a single subsidiary, US Metro Bank ("Bank"). On a consolidated basis, Bancorp earned $3.1 million in the third quarter of 2026, compared to $3.5 million in the second qu
  6. Travere Therapeutics, Inc.Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA NephropathyFILSPARI achieved greater reductions in biomarkers linked to kidney inflammation and injury than maximum labeled dose irbesartan Findings provide further evidence of the biological effects of dual endothelin and angiotensin receptor antagonism and support FILSPARI as foundational treatment in IgAN SAN DIEGO, October 23, 2